Currently authorised for use in those aged over 12
European Health Regulators are examining an application for approval for the use of the Pfizer-BioNTech Covid-19 vaccine, in children aged 5 to 11.
The inolculation is currently authorised for use in those aged 12 and over.
The European Medicines Agency says it will review the data on the vaccine, including results from an ongoing clinical study, in order to decide whether to recommend extending its use.
The EMA says the evaluation is expected to take a couple of months.
The vaccine was first authorised for use in adults, in December 2020.
EMA starts evaluating an application to extend the use of BioNTech/Pfizer’s COVID-19 vaccine, #Comirnaty, to children aged 5 to 11.
— EU Medicines Agency (@EMA_News) October 18, 2021
Read the full press release:
👉https://t.co/j07hskkjRO#COVID19vaccines pic.twitter.com/EENKB10NcV

Two Teenagers Among Those Dead After Bus Collides With Train In Belgium
Cabinet Briefing On Occupied Territories Bill This Morning
Trump Claims Iran Peace Talks Are Proceeding Nicely
Flotilla Detainees Claim Multiple Sexual Assaults Took Place While In Israeli Custody
Clane Student Wins Big At International Science Fair In Arizona
"A Lot Of People Got Beaten Badly": Sallins Man Gives Update After Last Month's Intercepted Gaza Flotilla